PMV Pharmaceuticals (PMVP) to Release Earnings on Thursday

PMV Pharmaceuticals (NASDAQ:PMVP - Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Thursday, March 6th. Analysts expect PMV Pharmaceuticals to post earnings of ($0.37) per share for the quarter.

PMV Pharmaceuticals Trading Down 2.8 %

PMVP stock traded down $0.04 during trading on Friday, reaching $1.37. 73,150 shares of the stock were exchanged, compared to its average volume of 138,876. The company has a market capitalization of $70.89 million, a P/E ratio of -1.37 and a beta of 1.46. PMV Pharmaceuticals has a twelve month low of $1.32 and a twelve month high of $2.26. The stock has a 50 day simple moving average of $1.43 and a 200-day simple moving average of $1.52.

Analyst Upgrades and Downgrades

Separately, Oppenheimer raised PMV Pharmaceuticals from a "market perform" rating to an "outperform" rating and set a $6.00 price target for the company in a report on Friday, November 8th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, PMV Pharmaceuticals has an average rating of "Buy" and a consensus price target of $5.50.

PMV Pharmaceuticals Company Profile

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function.